494.93歐元2.43(0.49%)
2023/12/08更新
績效 / 1月1.17%
3月0.72%
1年0.04%
晨星評等-
- 1.現金0.00%
- 2.股票33.74%
- 3.債券0.00%
- 4.其他66.26%
- 1.美國66.26%
- 2.歐洲不包含歐元區20.75%
- 3.英國5.14%
- 4.日本4.57%
- 5.歐元區1.64%
- 1.健康護理97.74%
- 2.工業1.35%
- 3.基本物料0.50%
- 4.防守性消費0.42%
- 1.UnitedHealth Group Inc9.76%
- 2.Novo Nordisk A/S Class B8.61%
- 3.Eli Lilly and Co7.22%
- 4.Roche Holding AG5.87%
- 5.Vertex Pharmaceuticals Inc5.60%
- 6.Amgen Inc5.40%
- 7.Elevance Health Inc5.19%
- 8.GSK PLC5.14%
- 9.Gilead Sciences Inc5.12%
- 10.Regeneron Pharmaceuticals Inc4.72%
- 1.現金0.00%
- 2.股票33.74%
- 3.債券0.00%
- 4.其他66.26%
- 1.健康護理97.74%
- 2.工業1.35%
- 3.基本物料0.50%
- 4.防守性消費0.42%
- 1.美國66.26%
- 2.歐洲不包含歐元區20.75%
- 3.英國5.14%
- 4.日本4.57%
- 5.歐元區1.64%
- 1.UnitedHealth Group Inc9.76%
- 2.Novo Nordisk A/S Class B8.61%
- 3.Eli Lilly and Co7.22%
- 4.Roche Holding AG5.87%
- 5.Vertex Pharmaceuticals Inc5.60%
- 6.Amgen Inc5.40%
- 7.Elevance Health Inc5.19%
- 8.GSK PLC5.14%
- 9.Gilead Sciences Inc5.12%
- 10.Regeneron Pharmaceuticals Inc4.72%